Skip to main
DOCS
DOCS logo

Doximity (DOCS) Stock Forecast & Price Target

Doximity (DOCS) Analyst Ratings

Based on 19 analyst ratings
Buy
Strong Buy 21%
Buy 32%
Hold 37%
Sell 5%
Strong Sell 5%

Bulls say

Doximity Inc. has experienced robust growth in its point-of-care (POC) and formulary offerings, achieving over 100% growth during the recent buying season, which reflects strong demand for its services among medical professionals. The company's stock has risen 3.2% since September 8, indicative of positive market sentiment following a recent Memorandum, and suggests a favorable outlook for future performance. Additionally, the second-quarter guidance appears attainable, with the potential for upside, supported by increased visibility and upfront buying from expanded service offerings.

Bears say

Doximity is facing a challenging outlook due to revisions in downward guidance from its pharmaceutical clients, attributed to the prevailing economic uncertainty, which impacts the company's growth prospects for FY'23 and FY'24. Additionally, Doximity's shares are expensive compared to its software peers, which could lead to increased volatility if the company's performance fails to meet lofty investor expectations. The heightened scrutiny on financial results suggests that any failure to provide positive guidance could lead to significant market disappointment.

Doximity (DOCS) has been analyzed by 19 analysts, with a consensus rating of Buy. 21% of analysts recommend a Strong Buy, 32% recommend Buy, 37% suggest Holding, 5% advise Selling, and 5% predict a Strong Sell.

This aggregate rating is based on analysts' research of Doximity and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About Doximity (DOCS) Forecast

Analysts have given Doximity (DOCS) a Buy based on their latest research and market trends.

According to 19 analysts, Doximity (DOCS) has a Buy consensus rating as of Dec 13, 2025. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $68.11, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $68.11, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

Doximity (DOCS)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.